Not admitted · Vague or promotional

Section 'Irritability Associated with Autism…Problematic Data' of Abilify I. Otsuka's maintenance trial of aripiprazole for irritability in autistic children was negative (p=0.097) and the FDA declined a maintenance label. The author quotes the FDA reviewer ('It is unlikely that the results ... would significantly alter the clinical practice of prescribers ... it is likely that aripiprazole would be continued') and adopts the view that prescribers will keep using it regardless.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.